Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients

New Microbiologica

Volumn 26, Issue 2, 2003, Pages 141-149

  Merlino, C ^a   Cavallo, R ^a   Bergallo, M ^a   Giacchino, F ^b   Bollero, C ^a   Negro Ponzi, A ^a   Cavallo, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Civil Hospital   (Italy)

Author keywords

EBV; Q PCR; Renal transplant patients

Indexed keywords

CYCLOSPORIN A; METHYLPREDNISOLONE; TSUKUBAENOLIDE; VIRUS DNA;

ACCURACY; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EPSTEIN BARR VIRUS; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; LYMPHOPROLIFERATIVE DISEASE; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RECIPIENT; STATISTICAL SIGNIFICANCE; VIRUS INFECTION; VIRUS LOAD; BLOOD; CELL CULTURE; EVALUATION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; KIDNEY TRANSPLANTATION; METHODOLOGY; TIME; VIROLOGY;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

CELLS, CULTURED; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; POLYMERASE CHAIN REACTION; TIME FACTORS; VIRAL LOAD;

EID: 0038142677     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. ALFREY, E.J., FRIEDMAN, A.L., GROSSMAN, R.A., PERLOFF, L.J., NAJI, A., BARKER, C.F., MONTONE, K.T., TOMASZEWSKI, J.E., CHMIELEWSKI, C., HOLLAND, T., ZMIJEWSKI, C., and DAFOE, D.C. (1992). A recent decrease in the time to development of monomorphous and polymorphous post-transplant lymphoproliferative disorder. Transplantation, 54, 250-253.
2. ARMITAGE, J.M., KORMOS, R.L., STUART, R.S., FRICKER, F.J., GRIFFITH, B.P., NALESNIK, M., HARDESTY, R.L., and DUMMER, J.S. (1991). Post-transplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. Journal of Heart and Lung Transplantation, 10, 877-886.
3. BALDANTI, F., GROSSI, P., FURIONE, M., SIMONCINI, L., SARASINI, A., COMOLI, P., MACCARIO, R., FIOCCHI, R., and GERNA, G. (2000). High levels of Epstein-Barr Virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. Journal of Clinical Microbiology, 38, 613-619.
4. BOUBENIDER, S., HIESSE, C., GOUPY, C., KRIIA, F., MARCHAND, S., and CHARPENTIER, B. (1997). Incidence and consequences of post-transplant lymphoproliferative disorders. Journal of Nephrology, 10, 136-145.
5. COCKFIELD, S.M., PREIKSAITIS, J., HARVEY, E., JONES, C., HEBERT, D., KEOWN, P., and HALLORAN, P.F. (1991). Is sequential use of ALG and OKT3 in renal transplants associated with an increased incidence of fulminant posttransplant lymphoproliferative disorder? Transplantation Proceedings, 23, 1106-1109.
6. CRAIG, F.E., GULLEY M.L., and BANKS, P.M. (1993). Post-transplantation lymphoproliferative disorders. American Journal of Clinical Pathology, 99, 265-276.
7. DROUET, E., BROUSSET, P., FARES, F., ICART, J., VERNIOL, C., MEGGETTO, F., SCHLAIFER, D., DESMORAT-COAT, H., RIGAL-HUGUET, F., NIVELEAU, A., and DELSOL, G. (1999). High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's disease. Journal of Medical Virology, 57, 383-389.
8. GAERTNER, B.C., KORTMAN, K., SCHAEFER, M., MUELLER-LANTZSCH, N., SESTER, U., KAUL, H., and PEES, H. (2000). No correlation in Epstein-Barr virus reactivation between serologicals parameters and viral load: Journal of Clinical Microbiology, 38, 2458-2463.
9. GREEN, M., CACCIARELLI, T.V., MAZARIEGOS, G.V., SIGURDSSON, L., QU, L., ROWE, D.T., and REYES, J. (1998). Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipient during treatment for posttransplant lymphoproliferative disease. Transplantation, 66, 1641-1644.
10. HANTO, D.W., FRIZZERA, G., GAIL-PECZALSKA, K.J., and SIMMONS R.L. (1985). EB virus, immunodeficiency and B cell lymphoproliferation. Transplantation, 39, 461-472.
11. HANTO, D.W., SAKAMOTO, K., PURTILO, D.T., SIMMONS, R.L., and NAJARIAN J.S. (1981). The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders: clinical, pathologic and virologic correlation. Surgery, 90, 204-213.
12. HO, M. (1995). Risk factors and pathogenesis of post-transplant lymphoproliferative disorders. Transplant Proceedings, 27 (suppl. 1), 38-40.
13. HO, M., JAFFE, R., MILLER G., BREINIG, M.K., DUMMER, J.S., MAKOWKA, L., ATCHISON, R.W., KARRER, F., NALESNIK, M.A., and STARZL, T.E. (1988). The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation, 45, 719-727.
14. HO, M., MILLER, G., ATCHISON, R.W, BREINIG, M.K., DUMMER, J.S., ANDIMAN, W., STARZL, T.E., EASTMAN, R., GRIFFITH, B.P., HARDESTY, R.L. BAHNSON, H.T., HAKALA, T.R., and ROSENTHAL, T. (1985). Epstein-Barr virus infection and DNA hybridisation studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. Journal of Infectious Disease, 152, 876-886.
15. JABS, W.J., HENNIG, H., KITTEL, M. PETHIG, K., SMETS, F., BUCKSY, P, KIRCHNER, H., and WAGNER, H.J. (2001). Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for post-transplant lymphoproliferative disorders. Journal of Clinical Microbiology, 39, 564-569.
16. KENAGY, D.N., SCHLESINGER, Y., WECK, K., RITTER, J.H., GAUDREAULT-KEENER, M.M., and STORCH, G.A. (1995). Epstein-Barr virus DNA in peripheral blood leukocytes of patients with post-transplant lymphoproliferative disease. Transplantation, 60, 547-554.
17. KIMURA, H., MORITA, M., YABUTA, Y., KUZUSHIMA, K., KATO, K., KOJIMA, S., MATSUYAMA, T., and MORISHIMA T. (1999). Quantitative analysis of Epstein-Barr virus load by using a real -time PCR assay. Journal of Clinical Microbioliology, 37, 132-136.
18. LUCAS, K.G., BURTON, R.L., ZIMMERMAN, S.E., WANG, J., CORNETTA, K.G., ROBERTSON, K.A., LEE, C.H., and EMANUEL, D.J. (1998). Semi-quantitative Epstein Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood, 91, 3653-3661.
19. LUCAS, K.G., POLLOK, K.E., and EMANUEL, D.J. (1997). Post-transplant EBV induced lymphoproliferative disorders. Leukemia and Lymphoma, 25, 1-8.
20. MAMZER-BRUNEEL, M.F., BOURQUELOT, P., HERMINE, O., LEGENDRE, C., and KREIS, H. (1997). Treatment and prognosis of post-transplant lymphoproliferative disease. Annals of Transplantation, 2, 42-48.
21. MERLINO, C., CAVALLO, R., BERGALLO, M., GIORGI, S., FORGNONE, F., RE, D., SINESI, F., MUSSO, T., and NEGRO PONZI, A. (2001). Quantitative PCR in EBV-infected renal transplant patients. New Microbiologica, 24, 223-230.
22. MIYASHITA, E.M., YANG, B., LAM, K.M., CRAWFORD, D.H., and THORLEY-LAWSON, D.A. (1995). A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell, 80, 593-601.
23. NALESNIK, M.A. (1996).Posttransplantation lymphoproliferative disorders (PTLD): current perspectives. Seminary on Thoracic and Cardiovascular Surgery, 8, 139-148.
24. NALESNIK, M.A. (1998). Clinical and pathologic features of post-transplant lymphoproliferative disorders (PTLD). Springer Seminary on Immunopathology, 20, 325-342.
25. NIESTERS, H.G.M., VAN ESSER, J., FRIES, E., WOLTHERS, K.C., CORNELISSEN, J., and OSTERHAUS, A.D.M.E. (2000). Development of a real-time quantitative assay for detection of Epstein-Barr virus. Journal of Clinical Microbiology, 38, 712-715.
26. ORENTAS, R.J. (1998). Determination of Epstein-Barr virus (EBV) load by RT-PCR and cellular dilution. Molecular and Cellular Probes, 12, 427-430.
27. RICKINSON, A.B., and KIEFF, E. (2001). Epstein-Barr virus. In: Knipe DM and Howley PM. eds. "Fields - Virology", Vol. 2, Lippincott Williams Wilkins Publishers, Philadelphia, 2575-2628.
28. RIDDLER, S.A., BREINIG, M.C., and MCKNIGHT, J.L.C. (1994). Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of post-transplant lymphoproliferative disease in solid-organ transplant recipient. Blood, 84, 972-984.
29. ROWE, D.T., QU, L., REYES, J., JABBOUR, N., YUNIS, E., PUTNAM, P., TODO, S., and GREEN, M. (1997). Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patient with lymphoproliferative disorders. Journal of Clinical Microbiology, 35, 1612-1615.
30. SAVOIE, A., PERPETE, C., CARPENTIER, L., JONAS, J., and ALFIERI, C. (1994). Direct correlation between the load od Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood, 83, 2715-2722.
31. STARTZL, T.E., NALESNIK, M.A., PORTER, K.A., HO, M., IWATSUKI, S., GRIFFITH, B.P., ROSENTHAL, J.T., HAKALA, T.R., SHAW, B. V.JR., HARDESTY, R.L., ATCHINSON, R.W., JAFFE, R., and BAHNSON, H.T. (1984). Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet, i, 583-587.
32. STEVENS, S.J.C., VERSCHUUREN, E.A.M., PRONK, I., VAN DER BIJ, W., HARMSEN, M.C., THE, T.H., MEIJER, C.J.L.M., VAN DER BRULE, A.J.C., and MIDDLELDORP, J.M. (2001). Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of post-transplant lymphoproliferative disease in high-risk patients. Blood, 97, 1165-1171.
33. SWERDLOW, A.J., HIGGINGS, C.D., HUNT, B.J., THOMAS, A., BURKE, M.M., CRAWFORD, D.H., and YACOUB, M.H. (2000). Risk of lymphoid neoplasia after cardiothoracic transplantation. A cohort study of the relation to Epstein-Barr virus infection. Transplantation, 69, 897-904.
34. SWINNEN, L.J. (2000). Diagnosis and treatment of transplant-related lymphoma. Annals of Oncology, 11 (suppl. 1), 45-48.
35. SWINNEN, L.J., COSTANZO-NORDIN, M.R., FISHER, S.G., O'SULLIVAN, E.J., JOHNSON, M.R., HEROUX, A.L., DIZIKES, G.J., PIFARRE, R., and FISHER, R.I. (1990). Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. New England Journal of Medicine, 323, 1723-1728.
36. TELENTI, A., MARSHALL, W.F., and SMITH, T.F. (1990). Detection of Epstein-Barr virus by polymerase chian reaction. Journal of Clinical Microbiology, 28, 2187-2190.
37. WAGNER, H.J., FISCHER, L., JABS, W., HOLBE, M., PETHIG, K., and BUCKSY, P. (2002). Longitudinal analysis of Epstein-Barr viral load in plasma and peripheral blood mononuclear cells of transplanted patients by real time polymerase chain reaction. Transplantation, 74, 656-664.
38. WAGNER, H.J., WESSEL, M., JABS, W., SMETS, F., FISCHER, L., OFFNER, G., and BUCSKY, P. (2001). Patients at risk for development of postransplant lymphoproliferative disorder: plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction. Transplantation, 72, 1012-1019.
39. WAKEFIELD, A.J., Fox, J.D., SAWYERR, A.M., TAYLOR, J.E., SWEENIE, C.H., SMITH, M., EMERY, V.C., HUDSON, M., TEDDER, R.S., and POUNDER, R.E. (1992). Detection of Herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. Journal of Medical Virology, 38, 183-190.
40. YANG, J., TAO, Q., FLINN, I.W., MURRAY, P.G., POST, L.E., MA, H., PIANTADOSI, S., CALIGIURI, M.A., and AMBINDER, R.F. (2000). Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response. Blood, 96, 4055-4063.
41. ZIPETO, D., BALDANTI, F., ZELLA, D., FURIONE, M., CAVICCHINI, A., MILANESI, G., and GERNA, G. (1993). Quantification of human cytomegalovirus DNA in peripheral blood polymorphonuclear leukocytes of immunocompromised patients by the polymerase chain reaction. Journal of Virological Methods, 44, 45-56, 1993.